Severe malaria, Pascalian therapeutics and the US FDA
Published: January 12, 2022
Citation
White NJ, Watson JA, Simpson JA. Severe malaria, Pascalian therapeutics and the US FDA. Clin Infect Dis. 2022 Jan 12:ciac024. doi: 10.1093/cid/ciac024. Epub ahead of print. PMID: 35023549.